Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP539151.RAdASo5J6hI9BDjI1bDFyX7FSVfM8X6BhRk-90I9Eo1dQ130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP539151.RAdASo5J6hI9BDjI1bDFyX7FSVfM8X6BhRk-90I9Eo1dQ130_provenance.
• NP921450.RAsj83Zw52fvQTGRWpJhI60VgBKDGKKgQ78CaPmhW2rXw130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP921450.RAsj83Zw52fvQTGRWpJhI60VgBKDGKKgQ78CaPmhW2rXw130_provenance.
• assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP520188.RAjfS7-S6hl9fqW8Fd6wZYc76kRjva4VjS9F-fpQVtims130_provenance.
• NP219393.RARqw10_QInAHsB9RrbYeVu5rJIAGJe1ZvVIyaKDlUHps130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219393.RARqw10_QInAHsB9RrbYeVu5rJIAGJe1ZvVIyaKDlUHps130_provenance.
• NP389340.RAEEa7BEvbGKzKtdJAcU12yYWzGilRb07JT5kYlYspOMo130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP389340.RAEEa7BEvbGKzKtdJAcU12yYWzGilRb07JT5kYlYspOMo130_provenance.
• NP667369.RA6PItSI4R69XnOWPbuyltJ-jfpLlbpFws8wVBI8Xie3w130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP667369.RA6PItSI4R69XnOWPbuyltJ-jfpLlbpFws8wVBI8Xie3w130_provenance.
• NP638624.RA3YHxCwlTu0yOPgTEnGI-10a-JfzihQWd1fz7NQiPEnk130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP638624.RA3YHxCwlTu0yOPgTEnGI-10a-JfzihQWd1fz7NQiPEnk130_provenance.
• assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP667808.RAK7iHZP6hIMDXZhVEkuPOpDzExSivCAjIE7Bn8Un8b2c130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP667808.RAK7iHZP6hIMDXZhVEkuPOpDzExSivCAjIE7Bn8Un8b2c130_provenance.
• assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP247347.RAV9iQIy5d3m11-6eU8bz_ivqTifI5l6SKTrW5mtw__iA130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247347.RAV9iQIy5d3m11-6eU8bz_ivqTifI5l6SKTrW5mtw__iA130_provenance.
• NP219508.RAC1cF-i_sPUCM_i2Lpj6sSz-zwZSXTIArc96sKQ4jKno130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219508.RAC1cF-i_sPUCM_i2Lpj6sSz-zwZSXTIArc96sKQ4jKno130_provenance.
• NP247342.RAtntJYOQ0SxMQXF2aJt3r5era_tKBSn7zz8LxSO0qhGI130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247342.RAtntJYOQ0SxMQXF2aJt3r5era_tKBSn7zz8LxSO0qhGI130_provenance.
• NP247345.RArugGyQZsWXfVM2PuCI3tl6wp73A1B1gghZgFpIJf9XE130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247345.RArugGyQZsWXfVM2PuCI3tl6wp73A1B1gghZgFpIJf9XE130_provenance.
• NP219055.RA5LalcoDHau9CVWLYpfJXOnJlHsrmZkErHIGKeyA2ejg130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP219055.RA5LalcoDHau9CVWLYpfJXOnJlHsrmZkErHIGKeyA2ejg130_provenance.
• NP576828.RAP9l8cUqTGmwJvDUeP45IhuuYUvfhDcoEp3W1xyCVZkI130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP576828.RAP9l8cUqTGmwJvDUeP45IhuuYUvfhDcoEp3W1xyCVZkI130_provenance.
• NP577038.RAFpFBLCGKa6rcR4uyCYRWvvrgnwC1ltrlLqhm_5lu1k4130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577038.RAFpFBLCGKa6rcR4uyCYRWvvrgnwC1ltrlLqhm_5lu1k4130_provenance.
• NP577083.RAFMdPCCvTwvm9nN8O8hErL5awyC76NXCL20ls1JmE_eA130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP577083.RAFMdPCCvTwvm9nN8O8hErL5awyC76NXCL20ls1JmE_eA130_provenance.
• NP247341.RALRqk6uH23eeYFLVgjinuolgCnlnj2zfEwQXv5Kfb-5g130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247341.RALRqk6uH23eeYFLVgjinuolgCnlnj2zfEwQXv5Kfb-5g130_provenance.
• NP247346.RAxleUYnM29UVB4Nf4-It18qWg8CCl0NfBz4CYUtf8UlM130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247346.RAxleUYnM29UVB4Nf4-It18qWg8CCl0NfBz4CYUtf8UlM130_provenance.
• NP247348.RA6UcQ2DlJY7kicqy7Iw32NnWm_MjvyooWP35WX-wE9Ls130_assertion description "[Using these figures as cut-off points, elevated CK-19: ABL ratios were detected in peripheral-blood samples of 20 of 37 (54%) patients with metastatic breast cancer and in bone marrow samples of 14 of 23 (61%) patients with primary breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247348.RA6UcQ2DlJY7kicqy7Iw32NnWm_MjvyooWP35WX-wE9Ls130_provenance.